Glucose Metabolism Disorder in Obese Children Assessed by Continuous Glucose Monitoring System
Overview
Authors
Affiliations
Background: Continuous glucose monitoring system (CGMS) can measure glucose levels at 5-minute intervals over a few days, and may be used to detect hypoglycemia, guide insulin therapy, and control glucose levels. This study was undertaken to assess the glucose metabolism disorder by CGMS in obese children.
Methods: Eighty-four obese children were studied. Interstitial fluid (ISF) glucose levels were measured by CGMS for 24 hours covering the time for oral glucose tolerance test (OGTT). Impaired glucose tolerance (IGT), impaired fasting glucose (IFG), type 2 diabetic mellitus (T2DM) and hypoglycemia were assessed by CGMS.
Results: Five children failed to complete CGMS test. The glucose levels in ISF measured by CGMS were highly correlated with those in capillary samples (r=0.775, P<0.001). However, the correlation between ISF and capillary glucose levels was lower during the first hour than that in the later time period (r=0.722 vs r=0.830), and the ISF glucose levels in 69.62% of children were higher than baseline levels in the initial 1-3 hours. In 79 obese children who finished the CGMS, 2 children had IFG, 2 had IGT, 3 had IFG + IGT, and 2 had T2DM. Nocturnal hypoglycemia was noted during the overnight fasting in 11 children (13.92%).
Conclusions: Our data suggest that glucose metabolism disorder including hyperglycemia and hypoglycemia is very common in obese children. Further studies are required to improve the precision of the CGMS in children.
Simunovic M, Kumric M, Rusic D, Paradzik Simunovic M, Bozic J Diagnostics (Basel). 2025; 14(24.
PMID: 39767162 PMC: 11674695. DOI: 10.3390/diagnostics14242801.
Gottfried S, Pontiggia L, Newberg A, Laynor G, Monti D BMJ Open. 2022; 12(8):e061756.
PMID: 36008066 PMC: 9422846. DOI: 10.1136/bmjopen-2022-061756.
Use of continuous glucose monitoring in obesity research: A scoping review.
Hegedus E, Salvy S, Wee C, Naguib M, Raymond J, Fox D Obes Res Clin Pract. 2021; 15(5):431-438.
PMID: 34481746 PMC: 8502209. DOI: 10.1016/j.orcp.2021.08.006.
Taranu I, Lazea C, Cret V, Racataianu N, Iancu M, Bolboaca S Diagnostics (Basel). 2021; 11(3).
PMID: 33803348 PMC: 7999014. DOI: 10.3390/diagnostics11030485.
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D Diabetes Technol Ther. 2017; 19(S3):S25-S37.
PMID: 28585879 PMC: 5467105. DOI: 10.1089/dia.2017.0035.